Ab and Neurodegeneration

Principal Investigator
Paul Salvaterra, PhD
Beckman Research Institute of the City of Hope
Duarte, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$400,000
Active Dates
April 01, 2007 - March 31, 2011
Grant ID
A2007066
Goals
Our work is designed to investigate the role of certain peptides, both alone and in combination, as direct causes of chronic brain cell death. We will accomplish this by using a simplified genetically controlled model organism. We also believe that our preliminary observations indicate a new cellular pathway that may be responsible for Alzheimer’s related cell death. We will thus try and prove this hypothesis using genetic and drug based experimental strategies in our model system.
Summary
Chronic and progressive dying neurons are the major feature of Alzheimer’s disease that can best explain the clinical symptoms. More than 20 years of intensive research has implicated two toxic peptides generated from a larger normal protein as playing an important role in the disease process. It is not known, however, if these peptides are a cause of the disease or just an effect of some other problem in brain cells. Our work is designed to investigate the role of these peptides, both alone and in combination, as direct causes of chronic brain cell death. We will accomplish this by using a simplified genetically controlled model organism. We also believe that our preliminary observations indicate a new cellular pathway that may be responsible for Alzheimer’s related cell death. We will thus try and prove this hypothesis using genetic and drug based experimental strategies in our model system. If this new pathway is indeed responsible for cell death in Alzheimer’s disease our work could lead to the identification of new treatment and prevention strategies.
Progress Updates
Accumulation of beta-amyloid (Aβ) protein is thought to be one cause of Alzheimer’s disease. Using a genetic model organism (Drosophila melanogaster—also known as the “fruit fly), Dr. Paul Salvaterra and colleagues established a link between Aβ accumulation and abnormal cell maintenance activity, called autophagy. Autophagy maintains cells in a stable, constant condition, as well as protects them from various kinds of stress. Dr. Salvaterra demonstrated that expression in fly brains of one type of beta-amyloid protein, called Aβ42, but not another type, called Aβ40, causes a massive increase in abnormal autophagy activity that appears to lead to neurodegeneration. Counterintuitive to current assumptions about autophagy, Dr. Salvaterra demonstrated that decreased activity results in less Aβ42 accumulation while increased activity seems to contribute to a greater rate of neurotoxicity. These results suggest that Aβ42-dependent abnormal autophagy may be a key cellular event driving neurodegeneration in Alzheimer’s disease.
Grants
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Dong Kyu Kim, PhD
Current Organization
University of California
Alzheimer's Disease Research
Decoding Alzheimer’s Disease Genomes With Deep Learning
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Tatsuhiko Naito, MD, PhD
Current Organization
Icahn School of Medicine at Mount Sinai